Showing results (1731-1740 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|September 17, 2008
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation modelGuiqing Yao, Nick Freemantle, Marcus Flather, et al.Pharmacoeconomics|October 8, 2021
An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with SchizophreniaMarjanne A Piena, Natalie Houwing, Carla W Kraan, et al.Pharmacoeconomics|February 9, 2022
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility ApproachesElamin H ElbashaPharmacoeconomics|June 21, 2019
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United StatesThomas E Delea, Xinke Zhang, Jordan Amdahl, et al.Pharmacoeconomics|June 22, 2019
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative ReviewXiao Zang, Emanuel Krebs, Linwei Wang, et al.Pharmacoeconomics|June 20, 2019
Correction to: Publication of Decision Model Source Code: Attitudes of Health Economics AuthorsJoanna Emerson, Rachel Bacon, Alma Kent, et al.Pharmacoeconomics|October 26, 2021
Is an Orphan Drug's Cost-Effectiveness Associated with US Health Plan Coverage Restrictiveness?James D Chambers, Nikoletta M Margaretos, Daniel E Enright, et al.Pharmacoeconomics|March 25, 2022
Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and ChallengesManuel Gomes, Nick Latimer, Marta Soares, et al.Pharmacoeconomics|July 5, 2019
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013Elizabeth D Brouwer, Anirban Basu, Kai YeungPharmacoeconomics|August 11, 2018
The Impact of Moving from EQ-5D-3L to -5L in NICE Technology AppraisalsBecky Pennington, Monica Hernandez-Alava, Stephen Pudney, et al.Pageof 336